Search Result "SB1317/TG02"
Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor
Journal: Drug Metabolism Letters
Volume: 6 Issue: 1 Year: 2012 Page: 33-42
Author(s): Mohammed Khalid Pasha, Ramesh Jayaraman, Venkatesh Pilla Reddy, Pauline Yeo, Evelyn Goh,Anthony Williams, Kee Chuan Goh, Ethirajulu Kantharaj
Meet the Editorial Board Member
Journal: Current Drug Metabolism
Volume: 22 Issue: 10 Year: 2021 Page: 757-757
Author(s): R. Jayaraman
Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 17 Year: 2020 Page: 1535-1563
Author(s): Bharat Goel,Nancy Tripathi,Nivedita Bhardwaj,Shreyans K. Jain
Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2015 Page: 237-263
Author(s): Tahir Ali Chohan, Haiyan Qian, Youlu Pan, Jian-Zhong Chen